HERON THERAPEUTICS, INC. /DE/ Increase (Decrease) in Accounts Receivable
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Increase (Decrease) in Accounts Receivable of -$16.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $5.88M, a 391.88% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$5.89M.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $8.54M, a 27.88% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.12M.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts receivable for fiscal 2025 was $10.71M, a 42.88% decline from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts receivable for fiscal 2024 was $18.74M, a 131.75% increase from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts receivable for fiscal 2023 was $8.09M, a 51.13% decline from fiscal 2022.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts receivable for fiscal 2022 was $16.55M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $5.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$16.00K 10-Q · filed 2026-08-10 | $8.52M derived: sum of 3 quarters · filed 2026-08-10 | $9.64M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$5.89M 10-Q · filed 2026-05-11 | $2.65M derived: sum of 2 quarters · filed 2026-05-11 | $3.76M derived: sum of 3 quarters · filed 2026-05-11 | $4.96M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | $8.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.66M derived: sum of 2 quarters · filed 2026-02-26 | $10.85M derived: sum of 3 quarters · filed 2026-08-10 | $10.71M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.31M derived: sum of 2 quarters · filed 2026-08-10 | $2.17M 10-Q · filed 2025-11-04 | $14.01M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.05M 10-Q · filed 2026-08-10 | $12.89M derived: sum of 3 quarters · filed 2026-08-10 | $6.22M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | -$145.00K 10-Q · filed 2026-05-11 | $11.70M derived: sum of 2 quarters · filed 2026-05-11 | $5.03M derived: sum of 3 quarters · filed 2026-05-11 | $13.41M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $11.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.17M derived: sum of 2 quarters · filed 2026-02-26 | $13.56M derived: sum of 3 quarters · filed 2026-02-26 | $18.74M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$6.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.72M derived: sum of 2 quarters · filed 2025-11-04 | $6.90M 10-Q · filed 2025-11-04 | $3.24M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $8.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $13.57M 10-Q · filed 2025-08-08 | $9.91M derived: sum of 3 quarters · filed 2026-02-26 | -$2.98M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $5.18M 10-Q · filed 2025-05-06 | $1.53M derived: sum of 2 quarters · filed 2026-02-26 | -$11.37M derived: sum of 3 quarters · filed 2026-02-26 | $13.87M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$16.56M derived: sum of 2 quarters · filed 2026-02-26 | $8.69M derived: sum of 3 quarters · filed 2026-02-26 | $8.09M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$12.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $12.35M derived: sum of 2 quarters · filed 2024-11-12 | $11.75M 10-Q · filed 2024-11-12 | $21.61M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $25.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $24.64M 10-Q · filed 2024-08-06 | $34.51M derived: sum of 3 quarters · filed 2025-02-27 | $36.39M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | -$601.00K 10-Q · filed 2024-05-07 | $9.26M derived: sum of 2 quarters · filed 2025-02-27 | $11.14M derived: sum of 3 quarters · filed 2025-02-27 | $10.35M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $9.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.75M derived: sum of 2 quarters · filed 2025-02-27 | $10.95M derived: sum of 3 quarters · filed 2025-02-27 | $16.55M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.08M derived: sum of 2 quarters · filed 2023-11-14 | $6.69M 10-Q · filed 2023-11-14 | -$898.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.80M 10-Q · filed 2023-08-14 | -$2.78M derived: sum of 3 quarters · filed 2023-08-14 | -$2.31M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $5.60M 10-Q · filed 2023-05-11 | -$1.98M derived: sum of 2 quarters · filed 2023-05-11 | -$1.51M derived: sum of 3 quarters · filed 2023-05-11 | $2.58M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$7.12M derived: sum of 2 quarters · filed 2023-03-29 | -$3.03M derived: sum of 3 quarters · filed 2023-03-29 | -$6.35M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $471.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.56M derived: sum of 2 quarters · filed 2022-11-08 | $1.24M 10-Q · filed 2022-11-08 | $9.43M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $4.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $765.00K 10-Q · filed 2022-08-09 | $8.96M derived: sum of 3 quarters · filed 2022-08-09 | $5.11M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | -$3.33M 10-Q · filed 2022-05-09 | $4.87M derived: sum of 2 quarters · filed 2022-05-09 | $1.02M derived: sum of 3 quarters · filed 2022-05-09 | $3.71M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.35M derived: sum of 2 quarters · filed 2022-02-28 | $7.04M derived: sum of 3 quarters · filed 2022-02-28 | $1.97M 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$3.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$1.16M derived: sum of 2 quarters · filed 2021-11-03 | -$6.22M 10-Q · filed 2021-11-03 | -$33.30M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$2.38M 10-Q · filed 2021-08-09 | -$29.45M derived: sum of 3 quarters · filed 2022-02-28 | -$29.32M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$5.07M 10-Q · filed 2021-05-10 | -$32.14M derived: sum of 2 quarters · filed 2022-02-28 | -$32.01M derived: sum of 3 quarters · filed 2022-02-28 | -$39.20M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | -$27.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$26.94M derived: sum of 2 quarters · filed 2022-02-28 | -$34.13M derived: sum of 3 quarters · filed 2022-02-28 | -$24.77M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$7.05M derived: sum of 2 quarters · filed 2020-11-05 | $2.30M 10-Q · filed 2020-11-05 | $13.32M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | -$7.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $2.17M 10-Q · filed 2020-08-05 | $13.19M derived: sum of 3 quarters · filed 2021-02-24 | $20.93M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $9.36M 10-Q · filed 2020-05-06 | $20.37M derived: sum of 2 quarters · filed 2021-02-24 | $28.12M derived: sum of 3 quarters · filed 2021-02-24 | $36.29M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $11.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $18.77M derived: sum of 2 quarters · filed 2021-02-24 | $26.94M derived: sum of 3 quarters · filed 2021-02-24 | $22.78M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $7.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $15.92M derived: sum of 2 quarters · filed 2019-11-12 | $11.76M 10-Q · filed 2019-11-12 | $24.78M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $8.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $4.01M 10-Q · filed 2019-08-05 | $17.04M derived: sum of 3 quarters · filed 2020-03-02 | $27.27M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$4.16M 10-Q · filed 2019-05-09 | $8.86M derived: sum of 2 quarters · filed 2020-03-02 | $19.10M derived: sum of 3 quarters · filed 2020-03-02 | $27.39M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $13.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $23.26M derived: sum of 2 quarters · filed 2020-03-02 | $31.55M derived: sum of 3 quarters · filed 2020-03-02 | $39.91M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $10.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $18.52M derived: sum of 2 quarters · filed 2018-11-07 | $26.89M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $8.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $16.66M 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | $8.37M 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | $1.96M 10-K · filed 2019-02-22 | ||||
| 2011-12-31 | -$220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$220.00K derived: sum of 2 quarters · filed 2014-03-07 | $41.00K derived: sum of 3 quarters · filed 2014-03-07 | -$110.00K 10-K · filed 2014-03-07 | $110.00K 10-K · filed 2012-03-26 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $261.00K derived: sum of 2 quarters · filed 2012-11-05 | $110.00K 10-Q · filed 2012-11-05 | $328.00K derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-06-30 | $261.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $110.00K 10-Q · filed 2012-08-09 | $328.00K derived: sum of 3 quarters · filed 2013-03-01 | $356.00K derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-03-31 | -$151.00K 10-Q · filed 2012-05-10 | $67.00K derived: sum of 2 quarters · filed 2013-03-01 | $95.00K derived: sum of 3 quarters · filed 2013-03-01 | ||
| 2010-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $246.00K derived: sum of 2 quarters · filed 2013-03-01 | $61.00K 10-K · filed 2013-03-01 | ||
| 2010-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$157.00K 10-Q · filed 2011-11-07 | |||
| 2010-06-30 | -$185.00K 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | -$139.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |